Latest stories on PCSA
Processa Pharmaceuticals, Inc. (PCSA) files 8-K
SEC 8-K50 · neutralgeneral
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Insider52 · neutralproduct/pr
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire52 · neutralproduct/pr
Processa Pharmaceuticals names Gregory Flesher COO, adds three executives
The Fly56 · neutralproduct/pr
Processa Pharmaceuticals Names Gregory Flesher Chief Operating Officer
TipRanks53 · neutralgeneral
Processa Pharmaceuticals, Inc. (PCSA) files 8-K
SEC 8-K50 · neutralgeneral
Processa Pharmaceuticals Announces Key Leadership Appointments
GlobeNewswire56 · neutralproduct/pr
Processa Pharmaceuticals Announces Key Leadership Appointments
StockTitan56 · neutralproduct/pr
Processa Advances Immunology Pipeline With New Leadership, Financing
TipRanks61 · neutralproduct/pr
Processa Pharmaceuticals, Inc. (PCSA) files 8-K
SEC 8-K50 · neutralgeneral
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
GlobeNewswire64 · neutralm&a
Processa registers to sell 306.57M shares of common stock for holders
The Fly22 · bearishgeneral
8-K/A - Processa Pharmaceuticals, Inc. (PCSA) files 8-K
SEC 8-K50 · neutralgeneral
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Processa Pharmaceuticals, Inc. (PCSA) files 8-K
SEC 8-K50 · neutralgeneral
Processa Pharmaceuticals, Inc. (PCSA) M&A Call Prepared Remarks Transcript
Seeking Alpha50 · neutralm&a
Processa Pharmaceuticals, Inc. (PCSA) M&A Call - Slideshow
Seeking Alpha50 · neutralgeneral
Processa buys Vidya Therapeutics, raises $200 million for drug trials
Reuters58 · neutralm&a
Processa Pharmaceuticals acquires Vidya, raises strategic funding
TipRanks65 · bullishm&a
Processa Pharmaceuticals, Inc. (PCSA) files 8-K
SEC 8-K50 · neutralgeneral